Articles On Micro-X (ASX:MX1)

Title Source Codes Date
Dr Boreham’s Crucible: Hydrix

By Tim Boreham, Editor ASX code: ((HYD)) Market cap: $4.3m Shares on issue: 254,218,847 Financials (December half 2023): revenue $5.97m (down -17.5%), loss of $3.82m (-$1.96m deficit previously), cash of $847,277 (down -73.5%)* * After bala...

FNArena MX1 3 days ago
Closing Bell: Pretty shameless ASX taken to Task on Monday

  Local markets get smashed, drop 1.8pc All 11 ASX sectors down Small Caps led by Task Group   A record close on Friday has found a typically ASX200-flavoured follow-up on Monday after the last session in New York saw US semiconductor dar...

Stockhead MX1 2 weeks ago
ASX Health Winners February: Law of attrition applies but biotech is a long term game; Nyrada up 5x last month

ASX Health Index down -1.5% for February 76 biotechs rose, and 78 fell during the month But essentially, biotech is a long term game for investors   The S&P/ASX 200 Health Care [XHJ] struggled in February, finishing -1.5% lower and tr...

Stockhead MX1 3 weeks ago
FNArena Corporate Results Monitor – 29-02-2024

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((4DX)) - 4DMedical ((APM)) - APM Human Services International ((AMI)) - Aurelia Metals ((ACL)) - Australian Clinical Labs ((AVG)) - Australian Vintage ((AVD)) - Avada Gro...

FNArena MX1 1 month ago
Check Up: Big week in world of biotech after these 2 Nasdaq stocks announce breakthroughs

Viking Therapeutics doubled after results of weight loss drug trial Janux Therapeutics tripled on pancreatic cancer results We look at the recent best performing ASX health stocks   There were a couple of big news from the world of biotec...

Stockhead MX1 1 month ago
Allegra’s game-changing Spinal Cage device awaits FDA nod, as ASX medical device stocks make inroads

ASX medical devices to make inroads with FDA after a good year for drug developers FDA is reviewing Allegra’s Spinal Cage Device made from 3D-printed Sr-HT-Gahnite Stockhead reached out to Allegra’s board member, Dr Nick Hartnell   It’s b...

Stockhead MX1 4 months ago
Check Up: Biden-Xi meeting could finally end opioids crisis in the US; and recent ASX biotech winners

Xi and Biden set to agree on restricting fentanyl  Fentanyl is a synthetic opioid responsible for the opioids epidemic in the US We look at the best performing health stocks over the past couple of weeks   China’s President Xi is expected...

Stockhead MX1 4 months ago
ASX Health Stocks: Earnings season is in full swing. We pick three highlights from the Health sector

Quarterly earnings season is underway, and we’ve picked three highlights from the ASX Healthcare sector this morning.    Micro-X (ASX:MX1) Highlights: Strong improvement in Mobile DR sales and orders of $2.9m this quarter First payment rec...

Stockhead MX1 5 months ago
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff

News relating to Novo Nordisk’s Ozempic has led to a selloff in some ASX stocks CSL, FPH, and RMD fell heavily last week But Goldman analysts say they won’t change ratings on these 3 stocks   Goldman Sachs analysts said they will make no...

Stockhead MX1 5 months ago
Check Up: How supramolecular technology is used in biotech, and why L’Oréal wants to get its hands on it

L’Oréal to take minority stake in Chinese startup Shinehigh Innovation Shinehigh is developing supramolecular technology which could be used in the fashion industry Best and worst performing ASX biotechs over the past couple of weeks   Be...

Stockhead MX1 6 months ago
ScoPo’s Powerplays: Who remembers that time they died? Oh, and Ramsay Healthcare cops credit downgrade

ASX health sector falls in line with broader markets as macroeconomic factors continue to create uncertainty Fitch Ratings Agency downgraded the credit rating of Ramsay Health Care (ASX:RHC) to BBB- from BBB Botanix Pharmaceuticals expects...

Stockhead MX1 6 months ago
Micro-X lands $1.5m Rover win with Australian Government

Innovative X-ray technology specialist Micro-X (ASX: MX1) has been awarded a significant $1.5 million contract with the Australian government for its unique Micro-X Rover systems. The new purchase order comes after the company decided to un...

smallcaps.wpenginepowered.com MX1 6 months ago
ASX Today: Stocks to watch on Wednesday

Futures suggest the ASX will open slightly lower this morning as investors await the US Fed interest rates decision due this week. Back home, the Critical Minerals and Energy Investment Conference kicks off in Perth with representatives...

themarketherald.com.au MX1 6 months ago
Market Highlights: Instacart jumps on Nasdaq IPO debut, and 5 ASX small caps to watch today

ASX to track Wall Street and open lower Instacart jumped by 12pc on Nasdaq IPO debut A look at how the world’s biggest companies have changed from 1980 to today   Australian shares are poised to track Wall Street and open lower on Wednesd...

Stockhead MX1 6 months ago
Check Up: What is the FDA emergency use authorisation, and which ASX stocks were given approval?

The FDA has just approved an emergency use authorisation for new Covid-19 vaccines What is emergency use authorisation, and which ASX stocks have got it? We look at the best and worst performing ASX biotechs over the couple of weeks   On...

Stockhead MX1 6 months ago
ASX Biotech August Winners: Sector down despite CSL and Cochlear’s strong results, but don’t panic…

Earnings reports dominated headlines in August Despite solid results from ASX healthcare giants, the sector finished lower We take a look at which ASX healthcare stocks performed the best in August   August was all about earnings, and des...

Stockhead MX1 6 months ago
FNArena Corporate Results Monitor – 31-08-2023

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((29M)) - 29Metals ((AIM)) - Ai-Media Technologies ((AMI)) - Aurelia Metals ((BXB)) - Brambles ((C79)) - Chrysos ((CYG)) - Coventry Group ((DDR)) - Dicker Data ((EML)) - E...

FNArena MX1 6 months ago
Check Up: Australian biotech sector continues to be a magnet for US investors

Australian biotech has attracted US investments in the last five years Among ASX stocks to get funded from the US include Opthea We look at the  best and worst performing ASX biotechs over the past month   The Australian biotech sector co...

Stockhead MX1 6 months ago
Curvebeam AI CEO says medical devices beat drugs to revenue, massive market in medical imaging

Medical devices offer faster route to commercialisation than drugs How newly listed Curvebeam AI aims to grab market share Stockhead reached out to Curvebeam AI CEO, Greg Brown   Despite the recent rally, the ASX Healthcare Index (XHJ) is...

Stockhead MX1 6 months ago
Strokes cost the Australian economy billions, but these biotech players could change that

Stroke has long been recognised as being among Australia’s most costly disease groups.  It occurs when a blood vessel supplying blood to the brain either suddenly becomes blocked or ruptures and begins to bleed which can result in part of t...

Stockhead MX1 7 months ago
Check Up: Biotech is worth ‘US$4 trillion in 10 years’, and here’s where the smart money will go

Biotech could be a US$4 trillion industry in 10 years Genetic engineering and weight loss are two growing themes in the space We look at the best and worst performing ASX biotechs over the past month   Steve Jobs used to say that the most...

Stockhead MX1 7 months ago
ASX Biotech Winners in July: Down but far from out, here’s why biotechs could stage a comeback

The end of pandemic and higher rates have subdued biotech market But there are signs now the sector is making a comeback We take a look at the ASX Biotech Winners in July   The Covid-19 pandemic had produced windfalls for and attracted fa...

Stockhead MX1 7 months ago
ScoPo’s Powerplays: ASX health stocks rise as Volpara records third quarter of positive cashflow

ASX health stocks up 1% in the past five days in line with broader markets Volpara records third quarter of positive cashflow following successful growth strategy Gut health a popular theme at 17th Bioshares Biotech Summit along with immun...

Stockhead MX1 8 months ago
TMH Market Close: Rinehart in court over royalties at Hope Downs, Pilbara

Lawyers for descendants of the late Peter Wright were first on the stand today, taking on Gina Rinehart over ownership and royalties relating to Hope Downs iron ore operations in the Pilbara. It’s day one of the Supreme Court of Western...

themarketherald.com.au MX1 8 months ago
Micro-X [ASX:MX1] Secures $21 Million Contract Extension to Build Self-Screening Airport Checks

Micro-X shares were up by 28.57% after the announcement today of the extension of its contract with the DHS to build and test a self-screening airport module. The contract is worth up to AU$21 million and will see testing that will eventual...

MoneyMorning MX1 8 months ago
Micro-X subsidiary awarded contract extension to develop passenger self-screening modules for US airports

This content is created by Smallcaps Authors. [Author : Imelda Cotton] South Australian x-ray technology developer Micro-X (ASX: MX1) has confirmed its subsidiary company Micro-X Inc has been awarded a $21 million contract extension with...

SmallCaps MX1 8 months ago
ASX up 0.14% at noon: ACCC delays ANZ-Suncorp merger

At noon, the S&P/ASX 200 is 0.14 per cent higher at 7,324. Suncorp has confirmed that the Australian Competition & Consumer Commission (ACCC) has requested additional time to review ANZ's merger with Suncorp. The ACCC asked for the...

ShareCafe MX1 8 months ago
Stocks of the Hour: Micro-X, European Metals, Tamboran Resources

  Micro-X (ASX:MX1) extends contract with U.S. DHS to test self-screening modules at an airport. In response, Micro-X Inc. Chief Executive Officer of Americas and Chief Scientist, Brian Gonzales, commented: “This contract extension fully fu...

ShareCafe MX1 8 months ago
Stocks of the Hour: Micro-X, European Metals, Tamboran Resources

24 Jul 2023 - A snapshot of the stocks on the move, featuring Micro-X (ASX:MX1), European Metals (ASX:EMH) and Tamboran Resources (ASX:TBN).

FNN MX1 8 months ago
Top 10 at 10: Positive phase 1 trials and a $21m US govt contract

Stockhead’s Top 10 at 10, published at ~10.30am each trading day, highlights the best (and worst) performing ASX stocks in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest movers...

Stockhead MX1 8 months ago
ScoPo’s Powerplays: ASX health stocks fall in first week of FY23 as Mach 7 scores biggest deal in its history

ASX health stocks have fallen in the past five days in line with broader markets Mach7 wins a US$60 million Veterans contract – the most significant in its history Neuren completes recruitment for Phase II trial of NNZ-2591 in Phelan-McDer...

Stockhead MX1 8 months ago
Check Up: Brisbane based Vaxxas set to disrupt market with game-changing, needle-free vaccines

Brisbane-based biotech Vaxxas is working on needles-free vaccine The Nanopatch is said to be a “game changer” We look at the best and worst performing ASX biotechs over the past month   The world is anticipating a “game changer” as Brisba...

Stockhead MX1 9 months ago
Check Up: Here’s the handful of ASX small cap health stocks that actually pay dividends

Small cap health stocks are not known to pay dividends But there’s a handful of such stocks on the ASX that do pay dividends We look at the best and worst performing ASX biotechs over the past week   When we talk about dividend-paying hea...

Stockhead MX1 9 months ago
ASX Tech Stocks May: AI sends things that go beep soaring 11.6pc, outpacing benchmark

The ASX tech sector rallied 11.6% in May and is up 16.94% YTD, surpassing the S&P ASX 200 Audio Pixels tops May ASX tech winners following AGM comments by CEO and chairman Archer Materials performs strongly in May after key global part...

Stockhead MX1 9 months ago
ScoPo’s Powerplays: ASX health stocks… could be worse

ASX health stocks outperforming the broader market but remain flattish for week Several ASX health plays undertaking capital raising with more expected in H2 CY23 Micro-X successfully tests its Argus bomb detection unit opening door to US$...

Stockhead MX1 9 months ago
TMH Market Close: ASX200 slips into the red, dragged by real estate and energy sectors

The ASX200 shed 8.1 points on Tuesday or 0.11 per cent, just one day after its strongest advance since mid-April. The real estate and energy sectors were the biggest drags on the market, each down around 1 per cent. In the red Ma...

themarketherald.com.au MX1 9 months ago
CLOSING BELL: ASX closed 0.11% lower, because there was no one around last night to tell us what to do

ASX benchmark ends the day flat, but not for lack of trying to rise. Or fall Tech stocks fell hard at first light, but rallied to finish the day well out in front Despite a short-lived challenge from Audio Pixels, Micro-X has won the day i...

Stockhead MX1 9 months ago
ASX-listed Micro-X made a crucial bomb disposal breakthrough – and the US is watching

Micro-X Argus bomb detection unit successfully field tested opening door to US$1.8 billion market The device removes need for a bomb disposal technician to get up close to a suspect package Argus has attracted attention of key defence and...

Stockhead MX1 9 months ago
ScoPo’s (he’s back) Powerplays: ASX health stocks fall, Volpara ‘elephants’ strategy pays off

ASX health stocks fall 0.8% in the past five days in line with broader markets following latest rate hike Investors rewarding health stocks with near term catalysts in 2023, including Neuren and Impedimed Health imaging stock Volpara recor...

Stockhead MX1 10 months ago
CLOSING BELL: And with one swift tug, we all get to learn what it’s like to be pantsed by the RBA

RBA Board kicks the nation in the goolies again, demanding another 25 basis points Investors seemingly caught by surprise, tanking the market in a matter of minutes Pinnacle Minerals let off the leash by the ASX, but still ahead of the gam...

Stockhead MX1 10 months ago
Check Up: Healthcare is ripe for AI disruption, and Telix Pharma’s first $100m quarterly sales

Artificial intelligence is set to disrupt the healthcare sector AI could also help in drugs discovery Telix delivers first quarterly revenue of $100 million   Moody’s Analytics’ chief economist, Mark Zandi, said the healthcare industry’s...

Stockhead MX1 10 months ago
Dr Boreham’s Crucible: Every sperm is sacred – and profitable

What’s wrong with our tadpoles, gentlemen? According to local fertility expert Prof John Aitken, sperm counts have roughly halved over the last 50 years and about 20 per cent of men shoot blanks. No-one’s sure why, but possible reasons incl...

Stockhead MX1 11 months ago
ScoPo’s Powerplays: ASX health stocks fall, Healius receives $1.52 billion takeover offer

ASX health stocks fall 0.9% in the past five days Healius receives a $1.52 billion takeover offer from Australian Clinical Labs Pharmaceutical wholesaler Sigma reports improved performance for the financial year Healthcare and life scien...

Stockhead MX1 1 year ago
Why growth is a positive for the ASX medical imaging sector

The medical imaging market size globally is forecast to reach $68.8 Billion by 2030 Several ASX health imaging stocks are establishing strong footholds and niches in sector Micro-X branching out from the medical sphere with its bomb detect...

Stockhead MX1 1 year ago
CLOSING BELL: $35 billion in sweet, sweet divvies suddenly makes it all seem worthwhile

ASX climbed as high as +1.3%, easing slightly to close up 0.9%. XEC Emerging Companies and Goldies duke it out to see who can close flattest. Investors are set to pocket $35 billion in dividends between now and EOFY.   Do Not Adjust Your...

Stockhead MX1 1 year ago
ScoPo’s Powerplays: ASX health stocks fall but keep watchful eye on upcoming catalysts

ASX health stocks fall 1.87% in the past five days as reporting season ends Healius moves to a statutory loss of ~$29 million following reduced demand for Covid-19 testing Catalysts in next few months for several ASX health stocks which co...

Stockhead MX1 1 year ago
FNArena Corporate Results Monitor – 28-02-2023

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ABY)) - Adore Beauty ((AIM)) - Ai-Media Technologies ((AGI)) - Ainsworth Game Technology ((ART)) - Airtasker ((AKE)) - Allkem ((APM)) - APM Human Services International...

FNArena MX1 1 year ago
ScoPo’s Powerplays: ASX health stocks rise, Mach 7 lands largest contract and posts record quarter

ASX health stocks rise 2.27% this week after finishing up 3.9% in January in strong start to 2023 Mach 7 posts a record quarter in sales after landing its largest ever contract in December EBR System’s pivotal trial into WiSE on schedule,...

Stockhead MX1 1 year ago
Check Up: The FDA refuses to give CBD a green light, but market doesn’t seem to care

The FDA declined regulate CBD-based supplements and food, citing safety reasons CBD products have grown exponentially in the marketplace We take a look at what it all means for the cannabis industry   The US FDA announced last week that:...

Stockhead MX1 1 year ago
Check Up: Japan’s startup OUI wants to halve the world’s blindness with its smartphone device

Japanese startup OUI is on a mission to halve the world’s blindness with its smartphone-based device Which ASX healthcare companies also have smartphone-based products? A quick look at the best and worst ASX healthcare stocks over the past...

Stockhead MX1 1 year ago